|
Miltenyi Biotec
dll4 pe vio770 mhd4 46 Dll4 Pe Vio770 Mhd4 46, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+dll4/DLL4+Antibody%2C+anti-human/pmc06066910__mmc3-296-47-51 Average 93 stars, based on 1 article reviews
dll4 pe vio770 mhd4 46 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
MedChemExpress
notch agonist Notch Agonist, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+dll4/Delta-like+4%2FDLL4%2C+Human/us12391919-237-4-17 Average 94 stars, based on 1 article reviews
notch agonist - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
R&D Systems
recombinant human dll4 ![]() Recombinant Human Dll4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+dll4/Human+DLL4+Antibody/bio_rxiv__2021__02__28__431778-134-0-12 Average 94 stars, based on 1 article reviews
recombinant human dll4 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
R&D Systems
human dll4 ![]() Human Dll4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+dll4/Recombinant+Human+DLL4+His-tag+Protein%2C+CF/pmc02673763-101-5-9 Average 93 stars, based on 1 article reviews
human dll4 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
R&D Systems
recombinant human fc linked notch ligands ![]() Recombinant Human Fc Linked Notch Ligands, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+dll4/Recombinant+Human+DLL4+Fc+Chimera+Protein%2C+CF/pmc12998526-275-7-12 Average 94 stars, based on 1 article reviews
recombinant human fc linked notch ligands - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
OriGene
human dll4 Human Dll4, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+dll4/DLL4+(NM_019074)+Human+Tagged+ORF+Clone/pmc08149476-117-0-3 Average 90 stars, based on 1 article reviews
human dll4 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
R&D Systems
dll4 ![]() Dll4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+dll4/DLL4+Antibody+(Smart+Targeting+patent+anti-DLL4)+-+Humanized/10__7554_slash_elife__32860-322-22-24 Average 91 stars, based on 1 article reviews
dll4 - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
OriGene
human dll4 gene hdll4 nm 019074 ![]() Human Dll4 Gene Hdll4 Nm 019074, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+dll4/DLL4+(NM_019074)+Human+Untagged+Clone/pmc11440056-379-1-6 Average 92 stars, based on 1 article reviews
human dll4 gene hdll4 nm 019074 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
OriGene
dll4 shrna ![]() Dll4 Shrna, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+dll4/DLL4+Human+shRNA+Plasmid+Kit/pmc06141339-48-9-11 Average 90 stars, based on 1 article reviews
dll4 shrna - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: bioRxiv
Article Title: DLL4 and PDGF-BB regulate migration of human iPSC-derived skeletal myogenic progenitors
doi: 10.1101/2021.02.28.431778
Figure Lengend Snippet: (A) Principal Component Analysis (PCA) showing mMuSC-derived myoblasts (left), human myoblasts (centre) and hiMPs (right). 4 cell lines were analysed with RNAseq in treated and untreated conditions for each cell population. Each point on the PCA represents a cell population. Additional information in Table S1,2. (B) Volcano plots visualising differentially expressed genes between untreated and DLL4 & PDGFBB-treated mMuSCs, human myoblasts and hiMPs. Red dots represent genes which display a positive fold-change in expression upon treatment with DLL4 & PDGF-BB whilst violet dots represent genes which are significantly downregulated. Differentially expressed genes required a P value of ≤ 0.05. (C) Heatmaps showing changes in expression of key myogenic ( MYOD, MYOGENIN ), perivascular ( PDGFRB, NG2, CD146, ALPL ) and NOTCH target ( HEY1, HES1 ) genes upon treatment with DLL4 & PDGF-BB in mMuSC-derived myoblasts (left), human myoblasts (middle) and hiMPs (right). Clustering was performed by genes/probes with Pearson correlation. Colour scale based on z-scores: red regions indicate high expression whilst blue regions indicate low expression. Dendrograms indicate the similarity of clusters as well as the orders in which clusters were assembled. (D) Validation of RNAseq data of panel (C) by real-time PCR analysis of the same myogenic, perivascular and NOTCH target transcripts in treated and untreated hiMPs (N=3; error bars; S.E.M.). Statistical analysis (paired t test) performed on ΔCt values whilst graphs were produced as fold change relative to untreated controls. (E) Curated dot plot Gene Ontology (GO; left), Kyoto Encyclopaedia of Genes and Genomes (KEGG; centre) and Reactome (right) enrichment analyses showing shared gene functions amongst the cell groups; numbers in brackets: genes analysed with a p value threshold set at 0.05; full lists in a dedicated spreadsheet available in Supplemental Information.
Article Snippet:
Techniques: Derivative Assay, Expressing, Biomarker Discovery, Real-time Polymerase Chain Reaction, Produced
Journal: bioRxiv
Article Title: DLL4 and PDGF-BB regulate migration of human iPSC-derived skeletal myogenic progenitors
doi: 10.1101/2021.02.28.431778
Figure Lengend Snippet: (A) Top cellular and molecular functions associated with DLL4 & PDGFBB modulation generated via ingenuity pathway analysis (IPA). Genes upregulated in the DLL4 & PDGFBB-treated hiMPs relative to the untreated control were subjected to IPA to reveal the predicted most significant associated functions. (B) Fluorescence microscopy images depicting Hoechst-positive nuclei of each cell at sequential time points. Coloured tails represent the locations of the nuclei at previous time points. (C) Unsupervised hierarchical clustering (Ward’s method) visualised with a t-SNE plot showing two distinct clusters (Silhouette Si = 0.19) (n = 408) (perplexity = 35). Cells pooled from 3 independent experimental replicates for each condition were used (untreated and DLL4 & PDGF-BB-treated). (D) Bar chart demonstrating normalised values for comparison of motility phenotypes between cells within the two clusters (mean ±SEM). Statistical significance based on Bonferroni-corrected t -test: all parameters except “hurst_RS” and “autocorr” are statistically significant between the two groups p<0.01 (data points: single cells pooled together from 3 independent experiments). (E) Bar graph displaying the proportions of control and DLL4 & PDGF-BB-treated cells within each cluster. (F) Functional protein association network analysis ( https://string-db.org ). The network view summarises predicted associations for proteins positively regulating cell migration common to all three datasets. The nodes are proteins and the edges represent the predicted functional associations. Red line: fusion evidence; Green line: neighbourhood evidence; Blue line: co-occurrence evidence; Purple line: experimental evidence; Yellow line: text mining evidence; Light blue line: database evidence; Black line: co-expression evidence. Blue nodes: GO:0030335 positive regulation of cell migration, Count in gene set: 8 of 452, false discovery rate: 0.0156. (G) P value-adjusted hierarchical clustering heatmap displaying hierarchical clustering of genes associated with leukocyte trans-endothelial migration (KEGG pathway: hsa04670; P set at 0.05). (H) Assessment of DLL4 & PDGF-BB-treated WT and genetically corrected DMD hiMP migration through a layer of endothelial cells. Representative images showing the lower side of the trans-well membrane on which treated and untreated hiMPs (stained with the transient dye CFDA, in green) are simultaneously seeded on HUVECs for 8 hours. Bar graphs quantifying the average number of CFDA-positive cells/ mm 2 , that have migrated through the endothelial layer in each considered condition. (N = 3). A minimum of 10 (1.5 mm 2 ) fields per condition was quantified (mean ±SEM). Scale bar: 250 μm. (I) Bar graph showing fold-change in trans-endothelial migration (mean ±SEM). Statistical significance based on one-way ANOVA with Bonferroni’s multiple comparison.
Article Snippet:
Techniques: Generated, Control, Fluorescence, Microscopy, Comparison, Functional Assay, Migration, Expressing, Membrane, Staining
Journal: Cell Reports Medicine
Article Title: NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells
doi: 10.1016/j.xcrm.2021.100279
Figure Lengend Snippet: Live cell imaging of TEC with anti-N3 mAb (green) bound to U20S-hN3 cells and co-cultured with HEK-DLL4 cells (red). Scale bar, 20 μm.
Article Snippet: Human DLL4 , Origene , Cat#RC212628.
Techniques:
Journal: Cell Reports Medicine
Article Title: NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells
doi: 10.1016/j.xcrm.2021.100279
Figure Lengend Snippet: Live cell imaging of TEC with anti-N3(i) mAb (green) bound to U20S-hN3 cells and co-cultured with HEK-DLL4 cells (red). Scale bar = 20 μm.
Article Snippet: Human DLL4 , Origene , Cat#RC212628.
Techniques:
Journal: Cell Reports Medicine
Article Title: NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells
doi: 10.1016/j.xcrm.2021.100279
Figure Lengend Snippet: Generation and characterization of therapeutic anti-NOTCH3 mAbs (A) NOTCH3-dependent report gene assay with NOTCH3-targeted and control mAbs. Data represent mean ± SEM from 3 biological replicates (n = 4 per replicate), ns, non-significant. (B) qRT-PCR of HES1 gene expression in treated cells. Data represent mean ± SD from 2 biological replicates (n = 3 per replicate), ns, non-significant. (C) NOTCH3 immunoblot from mAb-treated cells and xenografts. GAPDH is shown as a loading control. Schematic diagram of NOTCH3 cleavage events and protein fragments. M, mouse number. (D and E) Immunoblot using N- or C-terminal domain antibodies to detect NOTCH3 fragments after DLL4 activation in treated cells. β-actin is shown as a loading control. (F) Epitope mapping of anti-NOTCH3 mAbs using NRR3-NRR1 domain swap chimeric constructs. NRR3 domains are shown in black and NRR1 domains are shown in gray. Representative data represent mean (n = 2). (G) Binding interface of anti-N3(i) Fab on the NOTCH3-NRR domain as determined from the co-crystal structure is shown in red, LNR-A (green), LNR-B (beige), LNR-C (blue), HD1 (pink), and HD2 (magenta).
Article Snippet: Human DLL4 , Origene , Cat#RC212628.
Techniques: Gene Assay, Control, Quantitative RT-PCR, Gene Expression, Western Blot, Activation Assay, Construct, Binding Assay
Journal: Cell Reports Medicine
Article Title: NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells
doi: 10.1016/j.xcrm.2021.100279
Figure Lengend Snippet: Anti-NOTCH3 mAbs transendocytose into DLL4 ligand cells (A and B) TEC of labeled mAbs (green) that were bound to U2OS-hN3 cells and then co-cultured with HEK-DLL4 or HEK-parental cells (red) from live-cell confocal imaging. (A) Single optical sections of a U2OS-hN3 cell and a migrating HEK-DLL4 cell (asterisk) before and after contact (arrows). Scale bar, 10 μm. (B) z stack of maximum intensity projections. Arrows, anti-NOTCH3 mAbs inside HEK-DLL4 cells. (C) Confocal images of maximum intensity projections acquired from indirect immunofluorescence of mAbs bound to U2OS-hN3 cells (magenta) and then co-cultured with HEK-DLL4 (green) from. Dashed white line demarcates anti-NOTCH3 mAbs inside HEK-DLL4 cells. Scale bar, 10 μm.
Article Snippet: Human DLL4 , Origene , Cat#RC212628.
Techniques: Labeling, Cell Culture, Imaging, Immunofluorescence
Journal: Cell Reports Medicine
Article Title: NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells
doi: 10.1016/j.xcrm.2021.100279
Figure Lengend Snippet: NOTCH3-targeted ADCs induce cytotoxicity in both receptor and ligand cells (A) General structure of NOTCH3-targeted ADCs that were generated with mAbs, a cleavable dipeptide-based linker and the Aur0101 payload (blue). (B) NOTCH3-ADC induction of caspase-3/7 activity. Data represent mean ± SEM of 3 biological replicates (n = 3 per replicate). (C) In vitro cytotoxicity of NOTCH3-ADCs after control ( Control:siRNA ) or siRNA knockdown of NOTCH3 mRNA ( N3:siRNA ). Data represent mean ± SEM of 2 biological replicates (n = 3 per replicate). (D) In vitro cytotoxicity of NOTCH3-ADCs using parental MDA-MB-468 cells under 2D and 3D culture conditions. Data represent mean ± SEM (n = 3). (E and F) TEC of NOTCH3-ADCs induces caspase activity in HEK-DLL4 cells. (E) z stack of maximum intensity projections from live-cell confocal imaging of anti-N3(i) ADC bound to U2OS-hN3 cells and co-cultured with HEK-DLL4 cells labeled with pHrodo Red dextran. Caspase compartments (magenta line), pHrodo Red dextran compartments (blue line) and the merged image. (F) Percentage of the caspase-positive compartments that were calculated after treatment with NOTCH3-ADCs. Data represent mean ± SEM for 3 biological replicates (n = 15 fields imaged per replicate), ns, non-significant.
Article Snippet: Human DLL4 , Origene , Cat#RC212628.
Techniques: Generated, Activity Assay, In Vitro, Control, Knockdown, Imaging, Cell Culture, Labeling
Journal: Cell Reports Medicine
Article Title: NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells
doi: 10.1016/j.xcrm.2021.100279
Figure Lengend Snippet:
Article Snippet: Human DLL4 , Origene , Cat#RC212628.
Techniques: Control, Polymer, Plasmid Preparation, Blocking Assay, Electron Microscopy, Recombinant, Adjuvant, Antibody Labeling, RNAscope, Sequencing, Software
Journal: eLife
Article Title: MPDZ promotes DLL4-induced Notch signaling during angiogenesis
doi: 10.7554/elife.32860
Figure Lengend Snippet: Figure 1. MPDZ interacts with DLL1 and DLL4. (A, B) HEK293T cells were transfected with Citrine-MPDZ together with HA-tagged DLL1, HA-tagged DLL1DPDZ (lacking the PDZ-binding site), Flag-tagged DLL4 or Flag-tagged DLL4DPDZ. Antibodies against Citrine were used to immunoprecipitate Citrine-MPDZ. HA and FLAG-tagged proteins as well as MPDZ were detected by immunoblot (IB). Scheme shows structures of the constructs used for co-immunoprecipitation. Input, 10% of the immunoprecipitate. Cit-MPDZ, Citrine-MPDZ; IP, immunoprecipitation; neg.ctrl., negative control. (C, D) Figure 1 continued on next page
Article Snippet: Cells were suspended (106 cells/ml) and incubated with different fluoro- phores coupled to primary antibodies against DLL1 (FAB1818A, R & D Systems),
Techniques: Transfection, Binding Assay, Western Blot, Construct, Immunoprecipitation, Negative Control
Journal: eLife
Article Title: MPDZ promotes DLL4-induced Notch signaling during angiogenesis
doi: 10.7554/elife.32860
Figure Lengend Snippet: Figure 3. MPDZ recruits DLL1 and DLL4 to Nectin-2. (A) DLL1 and DLL4 full length and such lacking the PDZ-binding site (DPDZ) constructs containing a mCherry tag were expressed in HUVEC. Cells were stained with antibodies against DLL1 or DLL4. DLL1 and DLL4 surface expression of mCherry positive cells was analyzed by flow cytometry. n = 3; *, p<0.05; **, p<0.01 unpaired Student’s t-test. (B) Endothelial cells were isolated from Mpdz+/+
Article Snippet: Cells were suspended (106 cells/ml) and incubated with different fluoro- phores coupled to primary antibodies against DLL1 (FAB1818A, R & D Systems),
Techniques: Binding Assay, Construct, Staining, Expressing, Flow Cytometry, Isolation
Journal: Cell Reports Methods
Article Title: Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy
doi: 10.1016/j.crmeth.2024.100843
Figure Lengend Snippet:
Article Snippet: The
Techniques: Staining, Purification, Recombinant, Modification, Membrane, Cell Stimulation, Wright Stain, Software
Journal: World Journal of Gastroenterology
Article Title: Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
doi: 10.3748/wjg.v24.i34.3861
Figure Lengend Snippet: Delta-like ligand 4 expression promotes hepatitis B virus-associated hepatocellular carcinoma tumour growth in vivo . A: Western blot analyses of DLL4 expression in HepG2.2.15 stably transfected with shDLL4 or control vector. GAPDH was used as the loading control. B-D: HepG2.2.15 transfected with shDLL4 or control vector were subcutaneously injected into athymic nude mice (B) (1 × 10 7 cells per mouse, n = 4-6). Tumour volume (C) and tumour weights (D) are shown. At 18 d and 30 d after implantation, tumours were collected and analysed for DLL4, cleaved Notch1, VEGFA, and VEGFR2 by western blot. Beta-actin was used for the loading control. The blots cropped from different parts of the same gel (E). Band intensities from (E) were measured and the results are presented as the mean ± SD of three independent experiments (F). a P < 0.05; b P < 0.01; c P < 0.001.
Article Snippet: HepG2.2.15 cells line was transfected with a set of
Techniques: Expressing, Virus, In Vivo, Western Blot, Stable Transfection, Transfection, Control, Plasmid Preparation, Injection
Journal: World Journal of Gastroenterology
Article Title: Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
doi: 10.3748/wjg.v24.i34.3861
Figure Lengend Snippet: Suppression of Delta-like ligand 4 reduces tumour proliferation and neovasculature at the initiation stage of implantation. A and B: Immunohistochemical staining of CD31 (a-d) and Ki67 (e-h) shows mouse neovessels and tumour cell proliferation in paraffin sections of tumour xenografts, respectively. Five fields of each section were quantified for the amount of CD31 staining (C), and the percentage of Ki67 positive cells (D) in tumours transfected with shDLL4 or control vector at 18 d and 30 d after implantation. The tumour vasculature was measured after tumour implantation with shDLL4 HepG2.2.15 or control cells at 30 d (E). The data represent the mean ± SD. a P < 0.05; b P < 0.01; c P < 0.001.
Article Snippet: HepG2.2.15 cells line was transfected with a set of
Techniques: Immunohistochemical staining, Staining, Transfection, Control, Plasmid Preparation
Journal: World Journal of Gastroenterology
Article Title: Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
doi: 10.3748/wjg.v24.i34.3861
Figure Lengend Snippet: Suppression of Delta-like ligand 4 enhances hepatitis B virus viral replication (A), HBx mRNA expression (B), and HBs protein expression (C) in vivo . DNA, RNA, and proteins were extracted from tumour xenografts to analyse HBV viral components at 18 d and 30 d after implantation. The mRNA levels of human IFN-alpha (D), IFN-beta (E), and TNF-alpha (F) from tumours transfected with shDLL4 or control vectors were measured by quantitative RT-PCR and normalized to beta-actin mRNA expression. The data are represented by the mean ± SD. a P < 0.05; b P < 0.01.
Article Snippet: HepG2.2.15 cells line was transfected with a set of
Techniques: Virus, Expressing, In Vivo, Transfection, Control, Quantitative RT-PCR